{
    "root": "727913f6-9542-4a2d-9318-4b7ff521bffd",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Naproxen",
    "value": "20250320",
    "ingredients": [
        {
            "name": "NAPROXEN",
            "code": "57Y76R9ATQ"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "POVIDONE, UNSPECIFIED",
            "code": "FZ989GH94E"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        }
    ],
    "indications": "Naproxen tablets and naproxen sodium tablets are indicated for:\n                  the relief of the signs and symptoms of:\n                  \n                     \n                        •rheumatoid arthritis\n                     \n                        •osteoarthritis\n                     \n                        •ankylosing spondylitis\n                     \n                        •Polyarticular Juvenile Idiopathic Arthritis \n                  \n                  Naproxen tablets and naproxen sodium tablets are also indicated for:\n                  the relief of signs and symptoms of:\n                  \n                     \n                        •tendonitis\n                     \n                        •bursitis\n                     \n                        •acute gout\n                  \n                  the management of:\n                  \n                     \n                        •pain\n                     \n                        •primary dysmenorrhea",
    "contraindications": "Use the lowest effective dosage for shortest duration consistent with individual patient treatment goals. ( 2.1 ) Rheumatoid Arthritis, Osteoarthritis, and Ankylosing Spondylitis Naproxen tablets 250 mg (one-half tablet) 500 mg twice daily Naproxen sodium tablets 275 mg (one-half tablet) 550 mg twice daily The dose may be adjusted up or down depending on the clinical response of the patient. In patients who tolerate lower doses well, the dose may be increased to naproxen 1500 mg/ day for up to 6 months. Polyarticular Juvenile Idiopathic Arthritis Naproxen tablets may not allow for the flexible dose titration needed in pediatric patients with polyarticular juvenile idiopathic arthritis. A liquid formulation may be more appropriate. Recommended total daily dose of naproxen is approximately 10 mg/kg given in 2 divided doses. Dosing with naproxen tablets is not appropriate for children weighing less than 50 kilograms. Management of Pain, Primary Dysmenorrhea, and Acute Tendonitis and Bursitis Recommended starting dose 550 mg of naproxen sodium as naproxen sodium tablets followed by 550 mg every 12 hours or 275 mg every 6 to 8 hours as required. The initial total daily dose should not exceed 1375 mg of naproxen sodium. Thereafter, the total daily dose should not exceed 1100 mg of naproxen sodium. Naproxen sodium tablets are recommended for the management of acute painful conditions when prompt onset of pain relief is desired. Acute Gout Recommended starting dose 750 mg of naproxen tablets followed by 250 mg every 8 hours until the attack has subsided. Naproxen sodium tablets may also be used at a starting dose of 825 mg followed by 275 mg every 8 hours.",
    "warningsAndPrecautions": "Naproxen Tablets, USP 375 mg: oval, light orange colored, biconvex, uncoated tablets, engraved with ‘G 32’ on one side and ‘375’ on the other side. Packaged in light-resistant bottles of 100 and 500.\n                  Bottles of 20, NDC 68788-8844-2\n                  Bottles of 30, NDC 68788-8844-3\n                  Bottles of 60, NDC 68788-8844-6\n                  Bottles of 90, NDC 68788-8844-9\n                  Bottles of 100, NDC 68788-8844-1\n                  Bottles of 120, NDC 68788-8844-8\n                  Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature]. Dispense in well-closed containers.",
    "adverseReactions": "Naproxen tablets and naproxen sodium tablets are contraindicated in the following patients:\n                  \n                     \n                        •Known hypersensitivity (e.g., anaphylactic reactions and serious skin reactions) to naproxen or any components of the drug product [see Warnings and Precautions (5.7, 5.9)]\n                     \n                        •History of asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Severe, sometimes fatal, anaphylactic reactions to NSAIDs have been reported in such patients [see Warnings and Precautions (5.7, 5.8)]\n                     \n                        •In the setting of coronary artery bypass graft (CABG) surgery [see Warnings and Precautions (5.1)]"
}